{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-090522","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2024-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.211607+00:00","generated_at":"2026-05-31T08:55:43.719622+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Theriva Biologics announces 1-for-25 reverse stock split effective Aug 26, 2024","bullets":["Reverse split at 1-for-25 ratio; outstanding shares reduce from ~25.1M to ~1.0M.","Effective 12:01 a.m. ET on Aug 26, 2024; trading on split-adjusted basis same day.","Split intended to meet NYSE American per-share price listing requirements.","No fractional shares issued; holders of fractional shares get rounded up to next whole share.","CUSIP changes to 87164U 508; ticker remains TOVX."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-090522","json":"https://secwatch.observer/filing/0001104659-24-090522.json","markdown":"https://secwatch.observer/filing/0001104659-24-090522.md","text":"https://secwatch.observer/filing/0001104659-24-090522.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465924090522/0001104659-24-090522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465924090522/tm2421949d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:55:43.719622+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}